These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8901889)

  • 1. Mutagenicity and mutational spectra of 1,3-butadiene in the bone marrow of B6C3F1 lacI transgenic mice.
    Recio L; Sisk S; Meyer K; Pluta L; Bond JA
    Toxicology; 1996 Oct; 113(1-3):106-11. PubMed ID: 8901889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L; Saranko CJ; Steen AM
    Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms.
    Recio L; Steen AM; Pluta LJ; Meyer KG; Saranko CJ
    Chem Biol Interact; 2001 Jun; 135-136():325-41. PubMed ID: 11397399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung-specific mutagenicity and mutational spectrum in B6C3F1 lacI transgenic mice following inhalation exposure to 1,2-epoxybutene.
    Saranko CJ; Meyer KG; Pluta LJ; Henderson RF; Recio L
    Mutat Res; 2001 Jan; 473(1):37-49. PubMed ID: 11166025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of lacI mutants from bone marrow of B6C3F1 transgenic mice following inhalation exposure to 1,3-butadiene.
    Sisk SC; Pluta LJ; Bond JA; Recio L
    Carcinogenesis; 1994 Mar; 15(3):471-7. PubMed ID: 8118931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vivo mutagenicity and mutational spectrum at the lacI transgene recovered from the spleens of B6C3F1 lacI transgenic mice following a 4-week inhalation exposure to 1,3-butadiene.
    Recio L; Pluta LJ; Meyer KG
    Mutat Res; 1998 Jun; 401(1-2):99-110. PubMed ID: 9639685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of 1,3-butadiene mutagenicity in the bone marrow of B6C3F1 lacI transgenic mice (Big Blue): a review of mutational spectrum and lacI mutant frequency after a 5-day 625 ppm 1,3-butadiene exposure.
    Recio L; Meyer KG; Pluta LJ; Moss OR; Saranko CJ
    Environ Mol Mutagen; 1996; 28(4):424-9. PubMed ID: 8991073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased frequency of mutations at A:T base pairs in the bone marrow of B6C3F1 lacI transgenic mice exposed to 1,3-butadiene.
    Recio L; Meyer KG
    Environ Mol Mutagen; 1995; 26(1):1-8. PubMed ID: 7641703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of lacI mutants from transgenic fibroblasts exposed to 1,2-epoxybutene.
    Saranko CJ; Pluta LJ; Recio L
    Carcinogenesis; 1998 Nov; 19(11):1879-87. PubMed ID: 9854997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the mutations at Hprt exon 3 of T-lymphocytes from B6C3F1 mice and F344 rats exposed by inhalation to 1,3-butadiene or the racemic mixture of 1,2:3,4-diepoxybutane.
    Meng Q; Singh N; Heflich RH; Bauer MJ; Walker VE
    Mutat Res; 2000 Jan; 464(2):169-84. PubMed ID: 10648904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of transgenic mice for assessing the mutagenicity of 1,3-butadiene in vivo.
    Recio L; Bond JA; Pluta LJ; Sisk SC
    IARC Sci Publ; 1993; (127):235-43. PubMed ID: 8070869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the in vivo mutagenicity of ethylene oxide in the tissues of B6C3F1 lacI transgenic mice following inhalation exposure.
    Sisk SC; Pluta LJ; Meyer KG; Wong BC; Recio L
    Mutat Res; 1997 Jul; 391(3):153-64. PubMed ID: 9268040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenicity of butadiene and its epoxide metabolites: II. Mutational spectra of butadiene, 1,2-epoxybutene and diepoxybutane at the hprt locus in splenic T cells from exposed B6C3F1 mice.
    Cochrane JE; Skopek TR
    Carcinogenesis; 1994 Apr; 15(4):719-23. PubMed ID: 8149486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
    Walker VE; Meng Q
    Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo mutagenicity and mutation spectrum in the bone marrow and testes of B6C3F1 lacI transgenic mice following inhalation exposure to ethylene oxide.
    Recio L; Donner M; Abernethy D; Pluta L; Steen AM; Wong BA; James A; Preston RJ
    Mutagenesis; 2004 May; 19(3):215-22. PubMed ID: 15123787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of transgenic mice for studying mutagenicity induced by 1,3-butadiene.
    Recio L; Goldsworthy TL
    Toxicol Lett; 1995 Dec; 82-83():607-12. PubMed ID: 8597116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenicity of 1,3-butadiene at the Hprt locus of T-lymphocytes following inhalation exposures of female mice and rats.
    Meng Q; Henderson RF; Chen T; Heflich RH; Walker DM; Bauer MJ; Reilly AA; Walker VE
    Mutat Res; 1999 Aug; 429(1):107-25. PubMed ID: 10434027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenicity of 1,3-butadiene and its epoxide metabolites in human TK6 cells and in splenic T cells isolated from exposed B6C3F1 mice.
    Cochrane JE; Skopek TR
    IARC Sci Publ; 1993; (127):195-204. PubMed ID: 8070866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-specific mutant frequencies and mutational spectra in cyclophosphamide-treated lacI transgenic mice.
    Gorelick NJ; Andrews JL; deBoer JG; Young R; Gibson DP; Walker VE
    Environ Mol Mutagen; 1999; 34(2-3):154-66. PubMed ID: 10529740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.